Why and How - Verification of Compendial Methods - USP <1226>

Date: 12-Feb-13 to 12-Feb-13
Location: Online Webinar / California / United States
Category: Education Conferences & Trade Fairs

This USP <1226> webinar training will discuss the requirements of USP <1226>, what are FDA expectations related to method verification.

Why Should You Attend:

Analytics continues to be a challenging area for GMP compliance and the number of warning letters that are focused on this area continue to increase . Non-compliance to USP <1226> feature prominently in the 483s issued.


Who Will Benefit:

This course is intended to provide training on how to evaluate compendial methods in order to comply with USP <1226>

- QC personnel
- QC Supervisors and Management
- QA personnel
- QA Management
- Documentation management specialists
- Regulatory affairs personnel
- R&D Lab personnel
- R&D Lab Supervisors


Dr. Subbarao, received her Ph.D. in Bio-organic Chemistry from the Indian Institute of Technology, Bombay, India. Her hands-on industrial experience covers stability and laboratory cGMP systems for both biologics and conventional drugs. She has extensive experience in evaluation of analytical methods and method validation for products ranging from conventional drugs, well characterized proteins, vaccines, cell therapy and gene therapy products, ranging from pre-clinical phase to commercial phases.

Go to event website

EIN News provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See: